Your email has been successfully added to our mailing list.

×
0 0.00321543408360122 0 -0.00321543408360136 -0.00964630225080394 -0.00884244372990363 -0.00964630225080394 -0.00562700964630227
Stock impact report

Progenics Pharmaceuticals: An Underappreciated Company You Can't Afford To Ignore [Seeking Alpha]

PROGENICS PHARMACEUTICALS (PGNX) 
Last progenics pharmaceuticals earnings: 8/9 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: progenics.com
Company Research Source: Seeking Alpha
Progenics Pharmaceuticals: An Underappreciated Company You Can't Afford To IgnoreSummaryProgenics Pharmaceuticals is currently developing several drugs, including a treatment an ultra-rare cancer.Potential approval in a few months could be a big catalyst in early 2018.Risk and reward assessment here in the near to long term is highly favorable for the speculative investor. Show less Read more
Impact Snapshot
Event Time:
PGNX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for PGNX alerts
Opt-in for
PGNX alerts

from News Quantified
Opt-in for
PGNX alerts

from News Quantified